Global Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Regional Outlook and Forecast, 2021 - 2027

The Global Insulin Syringes Market size is expected to reach $2.1 billion by 2027, rising at a market growth of 4.5% CAGR during the forecast period.

Insulin controls the body's fat and glucose metabolism. It is a peptide hormone that is released by beta cells in the islets of Langerhans in the pancreas and aids in glucose metabolism regulation. An insulin syringe helps diabetic individuals get their insulin in the right dosages. Insulin syringes are made up of three parts: a needle, a barrel, and a plunger, and come in a variety of sizes. The needle is generally tiny and short, and it's coated with a specific substance like silicone to let it to slip into the skin with minimum discomfort.

The chamber in which the insulin is stored is known as the barrel. It's labelled with calibrations that show how many units of insulin are being administered. The plunger is a long, thin rod that glides up and down the barrel's length. Its function is to either pull insulin into the barrel or to release insulin from the barrel via the needle. Moreover, the capacity of the insulin syringe is determined by the intended insulin dosage to be given to the diabetic patient.

The world's ageing population and expanding number of diabetes patients are two significant reasons driving the market's growth. Furthermore, rising obesity rates and individuals adopting unhealthy lifestyles contribute to market development. The growth in health-care costs is a significant element driving demand for insulin syringes.

Companies may now offer their items online as a result of increased digitization. Insulin syringes are being sold online by a growing number of firms. Diabetes affects people in both urban and rural places across the world, with 64 percent of cases occurring in cities and 36% in rural areas.

Consumers from emerging countries account for the majority of the market. The rise in diabetes cases is a big motivator for the producers. Companies may take advantage of these distinct market characteristics by establishing a strong retail distribution infrastructure. Diabetes is predicted to cost USD 286 billion in direct healthcare expenditures per year for adults aged 20 to 79 over the world.

COVID-19 Impact Analysis

The World Health Organization (WHO) designated the COVID-19 pandemic a public health emergency of worldwide significance on January 30, 2020. COVID-19 has impacted over 210 nations throughout the world. Governments throughout the world have issued country-wide lockdowns and social distancing measures in response to the COVID-19 epidemic, in order to prevent the healthcare system from collapsing. Medical treatments and elective operations were also subjected to restrictions and bans by governments. These limitations continue to hinder the growth of many businesses, and the outbreak's immediate impact differs by industry.

Diabetes patients have a higher death rate than the overall population, according to research. People with diabetes require constant insulin (given through syringes or pens) and medical attention. The lack of or irregular supply of insulin devices as a result of the pandemic can have a major impact on the health of those with diabetes, particularly those afflicted with type 1 diabetes, who are completely reliant on insulin.

Market Growth Factors:

Availability of low-cost insulin and rising R&D spending

The introduction of generic insulin and the rapidly expanding demand for innovative insulin in the regulation of blood sugar levels across both type 1 and type 2 diabetes are expected to drive the growth of the insulin sector in the market during the projected period. Lispro, a generic version of rapid-acting Humalog insulin, was announced in March 2019 by Eli Lilly and Company. It will be accessible at much more affordable prices for diabetic patients.

Reduce the dependency on medical professionals

Insulin is often used by diabetic people since it is essential to be taken on a daily basis based on the type of diabetes. As a result, going to the doctor every day to get insulin injections can be costly and time consuming. People must carve out time from their busy schedules. People are searching for easier choices as their schedules get more hectic, therefore they utilise insulin syringes. When insulin syringes were utilised, patients reported a better overall injection experience. The size of insulin syringes varies depending on the amount of insulin used.

Marketing Restraining Factor:

High prices of insulin syringes

Lower-income nations are facing an unsustainable financial burden as the global market shifts away from human insulin, that can be generated at a low cost, and toward more expensive analogues (synthetic insulins). Human insulin is equally effective as analogues in most cases, however analogues are at least 1.5 times more expensive, and in certain cases 3 times more expensive; three multinational businesses dominate more than 90% of the insulin market, limiting the potential for smaller companies to compete for sales. Insulin expenses in the United States have been steadily growing for years, forcing diabetics and their families to make difficult decisions.

Disease Outlook

On the basis of Disease, the insulin syringe market is segmented into Type 1 Diabetes and Type 2 Diabetes. Type 2 Diabetes would account for the largest revenue share in the Insulin Syringes Market by 2020. This is due to an increase in the global prevalence of type-2 diabetes. According to the World Health Organization, around 462 million people worldwide have type 2 diabetes in 2019, accounting for 6.28 percent of the global population.

Syringe Size Outlook

The insulin syringe market is classified into three categories based on syringe size: 3/10 CC Syringe (0.3ml), 1/2 CC Syringe (0.5ml), 1CC Syringe (1ml), and Others. In year 2020, the 1ml syringe size has taken up the majority of sales. These syringes have a 2-unit graduation and are suited for dosages more than 50 units. For an adult who requires a considerable dose of insulin, a 1 mL syringe could be the best option.

End User Outlook

On the basis on End User, the insulin syringe market is categorized into Hospitals & Clinics, Homecare Settings, and Others. Due to the rising incidence of chronic illnesses like diabetes and obesity among the population, the hospital & clinics segment earned the biggest revenue share in the insulin syringes market. Furthermore, the rapidly growing geriatric population is a major driver of the insulin syringes industry. According to the American Diabetes Association, around 34.2 million individuals were diagnosed with diabetes in 2019, with 14.3 million of those over 65 years old suffering from the disease.

Insulin Syringes Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 1.5 Billion
Market size forecast in 2027	USD 2.1 Billion
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 4.5% from 2021 to 2027
Number of Pages	195
Number of Tables	350
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Disease, Syringe Size, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Availability of low-cost insulin and rising R&D spending Reduce the dependency on medical professionals
Restraints	High prices of insulin syringes

Regional Outlook

Based on region, the insulin syringes market is studied across North America, Europe, Asia Pacific, and LAMEA. North America would be the leading region in the Insulin Syringes Market by 2020, with the largest revenue share. This is mostly attributable to the region's sophisticated technology and new product releases by major market participants. Diabetes is the seventh largest cause of mortality in the United States, according to the Centers for Disease Control and Prevention (CDC). Diabetes is no longer confined to wealthy countries, but is increasingly affecting low- and middle-income countries.

Free Valuable Insights: Global Insulin Syringes Market size to reach USD 2.1 Billion by 2027

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Hindustan Syringes & Medical Devices Ltd., Novo Nordisk A/S, Biocon Limited, Eli Lilly and Company, Abbott Laboratories, Becton, Dickinson and Company, Cardinal Health, Inc., Medline Industries, Inc., Terumo Corporation, and Nipro Corporation.

Recent Strategy Deployed in Insulin Syringes Market

• Oct-2021: Eli Lilly formed a partnership with Cipla, the Indian multinational pharmaceutical company. This partnership focused on strengthening the outreach of Lilly’s Diabetes products, Trulicity, and Humalog in India. Additionally, Lilly would transfer all its rights with regulatory approvals to Cipla for promoting, distributing, and selling the Trulicity & Humalog in India.
• Aug-2021: Eli Lilly received approval from the US FDA approval for Lyumjev, rapid-acting insulin. Through this approval, the continuous 100 units/mL subcutaneous insulin infusion (CSII) with an insulin pump would help adults with type 1 and type 2 diabetes to regulate glycemic levels.
• Jul-2021: Biocon Biologics and Viatris received FDA approval for Semglee, the first interchangeable biosimilar product. Through this approval, pharmacy counters would witness, Lantus substitution Semglee, introduced in the market by the end of this year.
• Aug-2020: Biocon Biologics India, an entity of Biocon, teamed up with Mylan N.V, a generic and specialty Pharmaceuticals Company. Following this, the companies would introduce Semglee, an insulin glargine injection, in the U.S. Additionally, the companies aimed to assist pediatric as well as adult patients with type 1 and type 2 diabetes, to regulate high blood sugar, further, the product would be available in a vial and pre-filled pen presentations.
• Mar-2019: Eli Lilly unveiled a lower-priced version of Humalog of 100 units/mL in the United States. Through this launch, the company would offer a half-price insulin option of Humalog, to diabetic patients.
• Feb-2019: Abbott came into a partnership with Novo Nordisk, the multinational pharmaceutical company. Under this partnership, the companies would combine Novo Nordisk pre-filled dose data along with durable connected pens into the FreeStyle Libre system adopted by digital health devices. Moreover, this partnership aimed to provide connected insulin pens and continuous glucose monitoring in order to make diabetes management easier.
• Jan-2019: Becton and Dickinson Company received FDA approval for its second-generation BD Nano pen needle, more reliable subcutaneous injection. Through this approval, the product provides better diabetes management for reliable people who inject diabetes medications subcutaneously.
• Aug-2018: Novo Nordisk took over Ziylo, a supramolecular chemistry company. With this Acquisition, Novo Nordisk would strengthen its portfolio of synthetic glucose binding molecules, its platform technology, for therapeutic and diagnostic applications.

Scope of the Study

Market Segments Covered in the Report:

By Disease

• Type 2 Diabetes and
• Type 1 Diabetes

By Syringe Size

• 3/10 CC Syringe (0.3ml)
• 1/2 CC Syringe (0.5ml)
• 1CC Syringe (1ml) and
• Others

By End User

• Hospitals & Clinics
• Homecare Settings, and
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Hindustan Syringes & Medical Devices Ltd.
• Novo Nordisk A/S
• Biocon Limited
• Eli Lilly and Company
• Abbott Laboratories
• Becton, Dickinson and Company
• Cardinal Health, Inc.
• Medline Industries, Inc.
• Terumo Corporation
• Nipro Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Insulin Syringes Market, by Disease
1.4.2 Global Insulin Syringes Market, by Syringe Size
1.4.3 Global Insulin Syringes Market, by End User
1.4.4 Global Insulin Syringes Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Insulin Syringes Market by Disease
3.1 Global Type 2 Diabetes Market by Region
3.2 Global Type 1 Diabetes Market by Region

Chapter 4. Global Insulin Syringes Market by Syringe Size
4.1 Global 3/10 CC Syringe (0.3ml) Market by Region
4.2 Global 1/2 CC Syringe (0.5ml) Market by Region
4.3 Global 1CC Syringe (1ml) Market by Region
4.4 Global Other Syringe Size Market by Region

Chapter 5. Global Insulin Syringes Market by End User
5.1 Global Hospitals & Clinics Market by Region
5.2 Global Homecare Settings Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Insulin Syringes Market by Region
6.1 North America Insulin Syringes Market
6.1.1 North America Insulin Syringes Market by Disease
6.1.1.1 North America Type 2 Diabetes Market by Country
6.1.1.2 North America Type 1 Diabetes Market by Country
6.1.2 North America Insulin Syringes Market by Syringe Size
6.1.2.1 North America 3/10 CC Syringe (0.3ml) Market by Country
6.1.2.2 North America 1/2 CC Syringe (0.5ml) Market by Country
6.1.2.3 North America 1CC Syringe (1ml) Market by Country
6.1.2.4 North America Other Syringe Size Market by Country
6.1.3 North America Insulin Syringes Market by End User
6.1.3.1 North America Hospitals & Clinics Market by Country
6.1.3.2 North America Homecare Settings Market by Country
6.1.3.3 North America Others Market by Country
6.1.4 North America Insulin Syringes Market by Country
6.1.4.1 US Insulin Syringes Market
6.1.4.1.1 US Insulin Syringes Market by Disease
6.1.4.1.2 US Insulin Syringes Market by Syringe Size
6.1.4.1.3 US Insulin Syringes Market by End User
6.1.4.2 Canada Insulin Syringes Market
6.1.4.2.1 Canada Insulin Syringes Market by Disease
6.1.4.2.2 Canada Insulin Syringes Market by Syringe Size
6.1.4.2.3 Canada Insulin Syringes Market by End User
6.1.4.3 Mexico Insulin Syringes Market
6.1.4.3.1 Mexico Insulin Syringes Market by Disease
6.1.4.3.2 Mexico Insulin Syringes Market by Syringe Size
6.1.4.3.3 Mexico Insulin Syringes Market by End User
6.1.4.4 Rest of North America Insulin Syringes Market
6.1.4.4.1 Rest of North America Insulin Syringes Market by Disease
6.1.4.4.2 Rest of North America Insulin Syringes Market by Syringe Size
6.1.4.4.3 Rest of North America Insulin Syringes Market by End User
6.2 Europe Insulin Syringes Market
6.2.1 Europe Insulin Syringes Market by Disease
6.2.1.1 Europe Type 2 Diabetes Market by Country
6.2.1.2 Europe Type 1 Diabetes Market by Country
6.2.2 Europe Insulin Syringes Market by Syringe Size
6.2.2.1 Europe 3/10 CC Syringe (0.3ml) Market by Country
6.2.2.2 Europe 1/2 CC Syringe (0.5ml) Market by Country
6.2.2.3 Europe 1CC Syringe (1ml) Market by Country
6.2.2.4 Europe Other Syringe Size Market by Country
6.2.3 Europe Insulin Syringes Market by End User
6.2.3.1 Europe Hospitals & Clinics Market by Country
6.2.3.2 Europe Homecare Settings Market by Country
6.2.3.3 Europe Others Market by Country
6.2.4 Europe Insulin Syringes Market by Country
6.2.4.1 Germany Insulin Syringes Market
6.2.4.1.1 Germany Insulin Syringes Market by Disease
6.2.4.1.2 Germany Insulin Syringes Market by Syringe Size
6.2.4.1.3 Germany Insulin Syringes Market by End User
6.2.4.2 UK Insulin Syringes Market
6.2.4.2.1 UK Insulin Syringes Market by Disease
6.2.4.2.2 UK Insulin Syringes Market by Syringe Size
6.2.4.2.3 UK Insulin Syringes Market by End User
6.2.4.3 France Insulin Syringes Market
6.2.4.3.1 France Insulin Syringes Market by Disease
6.2.4.3.2 France Insulin Syringes Market by Syringe Size
6.2.4.3.3 France Insulin Syringes Market by End User
6.2.4.4 Russia Insulin Syringes Market
6.2.4.4.1 Russia Insulin Syringes Market by Disease
6.2.4.4.2 Russia Insulin Syringes Market by Syringe Size
6.2.4.4.3 Russia Insulin Syringes Market by End User
6.2.4.5 Spain Insulin Syringes Market
6.2.4.5.1 Spain Insulin Syringes Market by Disease
6.2.4.5.2 Spain Insulin Syringes Market by Syringe Size
6.2.4.5.3 Spain Insulin Syringes Market by End User
6.2.4.6 Italy Insulin Syringes Market
6.2.4.6.1 Italy Insulin Syringes Market by Disease
6.2.4.6.2 Italy Insulin Syringes Market by Syringe Size
6.2.4.6.3 Italy Insulin Syringes Market by End User
6.2.4.7 Rest of Europe Insulin Syringes Market
6.2.4.7.1 Rest of Europe Insulin Syringes Market by Disease
6.2.4.7.2 Rest of Europe Insulin Syringes Market by Syringe Size
6.2.4.7.3 Rest of Europe Insulin Syringes Market by End User
6.3 Asia Pacific Insulin Syringes Market
6.3.1 Asia Pacific Insulin Syringes Market by Disease
6.3.1.1 Asia Pacific Type 2 Diabetes Market by Country
6.3.1.2 Asia Pacific Type 1 Diabetes Market by Country
6.3.2 Asia Pacific Insulin Syringes Market by Syringe Size
6.3.2.1 Asia Pacific 3/10 CC Syringe (0.3ml) Market by Country
6.3.2.2 Asia Pacific 1/2 CC Syringe (0.5ml) Market by Country
6.3.2.3 Asia Pacific 1CC Syringe (1ml) Market by Country
6.3.2.4 Asia Pacific Other Syringe Size Market by Country
6.3.3 Asia Pacific Insulin Syringes Market by End User
6.3.3.1 Asia Pacific Hospitals & Clinics Market by Country
6.3.3.2 Asia Pacific Homecare Settings Market by Country
6.3.3.3 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Insulin Syringes Market by Country
6.3.4.1 China Insulin Syringes Market
6.3.4.1.1 China Insulin Syringes Market by Disease
6.3.4.1.2 China Insulin Syringes Market by Syringe Size
6.3.4.1.3 China Insulin Syringes Market by End User
6.3.4.2 Japan Insulin Syringes Market
6.3.4.2.1 Japan Insulin Syringes Market by Disease
6.3.4.2.2 Japan Insulin Syringes Market by Syringe Size
6.3.4.2.3 Japan Insulin Syringes Market by End User
6.3.4.3 India Insulin Syringes Market
6.3.4.3.1 India Insulin Syringes Market by Disease
6.3.4.3.2 India Insulin Syringes Market by Syringe Size
6.3.4.3.3 India Insulin Syringes Market by End User
6.3.4.4 South Korea Insulin Syringes Market
6.3.4.4.1 South Korea Insulin Syringes Market by Disease
6.3.4.4.2 South Korea Insulin Syringes Market by Syringe Size
6.3.4.4.3 South Korea Insulin Syringes Market by End User
6.3.4.5 Singapore Insulin Syringes Market
6.3.4.5.1 Singapore Insulin Syringes Market by Disease
6.3.4.5.2 Singapore Insulin Syringes Market by Syringe Size
6.3.4.5.3 Singapore Insulin Syringes Market by End User
6.3.4.6 Malaysia Insulin Syringes Market
6.3.4.6.1 Malaysia Insulin Syringes Market by Disease
6.3.4.6.2 Malaysia Insulin Syringes Market by Syringe Size
6.3.4.6.3 Malaysia Insulin Syringes Market by End User
6.3.4.7 Rest of Asia Pacific Insulin Syringes Market
6.3.4.7.1 Rest of Asia Pacific Insulin Syringes Market by Disease
6.3.4.7.2 Rest of Asia Pacific Insulin Syringes Market by Syringe Size
6.3.4.7.3 Rest of Asia Pacific Insulin Syringes Market by End User
6.4 LAMEA Insulin Syringes Market
6.4.1 LAMEA Insulin Syringes Market by Disease
6.4.1.1 LAMEA Type 2 Diabetes Market by Country
6.4.1.2 LAMEA Type 1 Diabetes Market by Country
6.4.2 LAMEA Insulin Syringes Market by Syringe Size
6.4.2.1 LAMEA 3/10 CC Syringe (0.3ml) Market by Country
6.4.2.2 LAMEA 1/2 CC Syringe (0.5ml) Market by Country
6.4.2.3 LAMEA 1CC Syringe (1ml) Market by Country
6.4.2.4 LAMEA Other Syringe Size Market by Country
6.4.3 LAMEA Insulin Syringes Market by End User
6.4.3.1 LAMEA Hospitals & Clinics Market by Country
6.4.3.2 LAMEA Homecare Settings Market by Country
6.4.3.3 LAMEA Others Market by Country
6.4.4 LAMEA Insulin Syringes Market by Country
6.4.4.1 Brazil Insulin Syringes Market
6.4.4.1.1 Brazil Insulin Syringes Market by Disease
6.4.4.1.2 Brazil Insulin Syringes Market by Syringe Size
6.4.4.1.3 Brazil Insulin Syringes Market by End User
6.4.4.2 Argentina Insulin Syringes Market
6.4.4.2.1 Argentina Insulin Syringes Market by Disease
6.4.4.2.2 Argentina Insulin Syringes Market by Syringe Size
6.4.4.2.3 Argentina Insulin Syringes Market by End User
6.4.4.3 UAE Insulin Syringes Market
6.4.4.3.1 UAE Insulin Syringes Market by Disease
6.4.4.3.2 UAE Insulin Syringes Market by Syringe Size
6.4.4.3.3 UAE Insulin Syringes Market by End User
6.4.4.4 Saudi Arabia Insulin Syringes Market
6.4.4.4.1 Saudi Arabia Insulin Syringes Market by Disease
6.4.4.4.2 Saudi Arabia Insulin Syringes Market by Syringe Size
6.4.4.4.3 Saudi Arabia Insulin Syringes Market by End User
6.4.4.5 South Africa Insulin Syringes Market
6.4.4.5.1 South Africa Insulin Syringes Market by Disease
6.4.4.5.2 South Africa Insulin Syringes Market by Syringe Size
6.4.4.5.3 South Africa Insulin Syringes Market by End User
6.4.4.6 Nigeria Insulin Syringes Market
6.4.4.6.1 Nigeria Insulin Syringes Market by Disease
6.4.4.6.2 Nigeria Insulin Syringes Market by Syringe Size
6.4.4.6.3 Nigeria Insulin Syringes Market by End User
6.4.4.7 Rest of LAMEA Insulin Syringes Market
6.4.4.7.1 Rest of LAMEA Insulin Syringes Market by Disease
6.4.4.7.2 Rest of LAMEA Insulin Syringes Market by Syringe Size
6.4.4.7.3 Rest of LAMEA Insulin Syringes Market by End User

Chapter 7. Company Profiles
7.1 Hindustan Syringes & Medical Devices Ltd.
7.1.1 Company Overview
7.2 Novo Nordisk A/S
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental & Regional Analysis
7.2.4 Research & Development Expenses
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisitions and Mergers:
7.3 Biocon Limited
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.4 Eli Lilly and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent Strategies and Developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Approvals and Trials:
7.5 Abbott Laboratories
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Becton, Dickinson and Company
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Approvals and Trials:
7.9 Terumo Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.10. Nipro Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses

TABLE 1 Global Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 2 Global Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 3 Global Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 4 Global Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 5 Global Type 2 Diabetes Market by Region, 2017 - 2020, USD Million
TABLE 6 Global Type 2 Diabetes Market by Region, 2021 - 2027, USD Million
TABLE 7 Global Type 1 Diabetes Market by Region, 2017 - 2020, USD Million
TABLE 8 Global Type 1 Diabetes Market by Region, 2021 - 2027, USD Million
TABLE 9 Global Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 10 Global Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 11 Global 3/10 CC Syringe (0.3ml) Market by Region, 2017 - 2020, USD Million
TABLE 12 Global 3/10 CC Syringe (0.3ml) Market by Region, 2021 - 2027, USD Million
TABLE 13 Global 1/2 CC Syringe (0.5ml) Market by Region, 2017 - 2020, USD Million
TABLE 14 Global 1/2 CC Syringe (0.5ml) Market by Region, 2021 - 2027, USD Million
TABLE 15 Global 1CC Syringe (1ml) Market by Region, 2017 - 2020, USD Million
TABLE 16 Global 1CC Syringe (1ml) Market by Region, 2021 - 2027, USD Million
TABLE 17 Global Other Syringe Size Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Other Syringe Size Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 20 Global Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 21 Global Hospitals & Clinics Market by Region, 2017 - 2020, USD Million
TABLE 22 Global Hospitals & Clinics Market by Region, 2021 - 2027, USD Million
TABLE 23 Global Homecare Settings Market by Region, 2017 - 2020, USD Million
TABLE 24 Global Homecare Settings Market by Region, 2021 - 2027, USD Million
TABLE 25 Global Others Market by Region, 2017 - 2020, USD Million
TABLE 26 Global Others Market by Region, 2021 - 2027, USD Million
TABLE 27 Global Insulin Syringes Market by Region, 2017 - 2020, USD Million
TABLE 28 Global Insulin Syringes Market by Region, 2021 - 2027, USD Million
TABLE 29 North America Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 30 North America Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 31 North America Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 32 North America Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 33 North America Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 34 North America Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 35 North America Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 36 North America Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 37 North America Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 38 North America Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 39 North America 3/10 CC Syringe (0.3ml) Market by Country, 2017 - 2020, USD Million
TABLE 40 North America 3/10 CC Syringe (0.3ml) Market by Country, 2021 - 2027, USD Million
TABLE 41 North America 1/2 CC Syringe (0.5ml) Market by Country, 2017 - 2020, USD Million
TABLE 42 North America 1/2 CC Syringe (0.5ml) Market by Country, 2021 - 2027, USD Million
TABLE 43 North America 1CC Syringe (1ml) Market by Country, 2017 - 2020, USD Million
TABLE 44 North America 1CC Syringe (1ml) Market by Country, 2021 - 2027, USD Million
TABLE 45 North America Other Syringe Size Market by Country, 2017 - 2020, USD Million
TABLE 46 North America Other Syringe Size Market by Country, 2021 - 2027, USD Million
TABLE 47 North America Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 48 North America Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 49 North America Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 50 North America Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 51 North America Homecare Settings Market by Country, 2017 - 2020, USD Million
TABLE 52 North America Homecare Settings Market by Country, 2021 - 2027, USD Million
TABLE 53 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 54 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 55 North America Insulin Syringes Market by Country, 2017 - 2020, USD Million
TABLE 56 North America Insulin Syringes Market by Country, 2021 - 2027, USD Million
TABLE 57 US Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 58 US Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 59 US Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 60 US Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 61 US Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 62 US Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 63 US Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 64 US Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 65 Canada Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 66 Canada Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 67 Canada Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 68 Canada Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 69 Canada Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 70 Canada Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 71 Canada Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 72 Canada Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 73 Mexico Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 74 Mexico Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 75 Mexico Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 76 Mexico Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 77 Mexico Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 78 Mexico Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 79 Mexico Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 80 Mexico Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 81 Rest of North America Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 82 Rest of North America Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 83 Rest of North America Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 84 Rest of North America Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 85 Rest of North America Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 86 Rest of North America Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 87 Rest of North America Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 88 Rest of North America Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 89 Europe Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 90 Europe Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 91 Europe Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 92 Europe Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 93 Europe Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 94 Europe Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 95 Europe Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 96 Europe Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 97 Europe Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 98 Europe Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 99 Europe 3/10 CC Syringe (0.3ml) Market by Country, 2017 - 2020, USD Million
TABLE 100 Europe 3/10 CC Syringe (0.3ml) Market by Country, 2021 - 2027, USD Million
TABLE 101 Europe 1/2 CC Syringe (0.5ml) Market by Country, 2017 - 2020, USD Million
TABLE 102 Europe 1/2 CC Syringe (0.5ml) Market by Country, 2021 - 2027, USD Million
TABLE 103 Europe 1CC Syringe (1ml) Market by Country, 2017 - 2020, USD Million
TABLE 104 Europe 1CC Syringe (1ml) Market by Country, 2021 - 2027, USD Million
TABLE 105 Europe Other Syringe Size Market by Country, 2017 - 2020, USD Million
TABLE 106 Europe Other Syringe Size Market by Country, 2021 - 2027, USD Million
TABLE 107 Europe Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 108 Europe Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 109 Europe Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 110 Europe Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 111 Europe Homecare Settings Market by Country, 2017 - 2020, USD Million
TABLE 112 Europe Homecare Settings Market by Country, 2021 - 2027, USD Million
TABLE 113 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 114 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 115 Europe Insulin Syringes Market by Country, 2017 - 2020, USD Million
TABLE 116 Europe Insulin Syringes Market by Country, 2021 - 2027, USD Million
TABLE 117 Germany Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 118 Germany Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 119 Germany Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 120 Germany Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 121 Germany Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 122 Germany Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 123 Germany Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 124 Germany Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 125 UK Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 126 UK Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 127 UK Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 128 UK Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 129 UK Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 130 UK Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 131 UK Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 132 UK Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 133 France Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 134 France Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 135 France Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 136 France Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 137 France Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 138 France Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 139 France Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 140 France Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 141 Russia Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 142 Russia Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 143 Russia Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 144 Russia Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 145 Russia Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 146 Russia Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 147 Russia Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 148 Russia Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 149 Spain Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 150 Spain Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 151 Spain Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 152 Spain Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 153 Spain Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 154 Spain Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 155 Spain Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 156 Spain Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 157 Italy Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 158 Italy Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 159 Italy Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 160 Italy Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 161 Italy Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 162 Italy Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 163 Italy Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 164 Italy Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 165 Rest of Europe Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 166 Rest of Europe Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 167 Rest of Europe Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 168 Rest of Europe Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 169 Rest of Europe Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 170 Rest of Europe Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 171 Rest of Europe Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 172 Rest of Europe Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 173 Asia Pacific Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 174 Asia Pacific Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 175 Asia Pacific Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 176 Asia Pacific Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 177 Asia Pacific Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 178 Asia Pacific Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 179 Asia Pacific Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 180 Asia Pacific Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 181 Asia Pacific Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 182 Asia Pacific Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 183 Asia Pacific 3/10 CC Syringe (0.3ml) Market by Country, 2017 - 2020, USD Million
TABLE 184 Asia Pacific 3/10 CC Syringe (0.3ml) Market by Country, 2021 - 2027, USD Million
TABLE 185 Asia Pacific 1/2 CC Syringe (0.5ml) Market by Country, 2017 - 2020, USD Million
TABLE 186 Asia Pacific 1/2 CC Syringe (0.5ml) Market by Country, 2021 - 2027, USD Million
TABLE 187 Asia Pacific 1CC Syringe (1ml) Market by Country, 2017 - 2020, USD Million
TABLE 188 Asia Pacific 1CC Syringe (1ml) Market by Country, 2021 - 2027, USD Million
TABLE 189 Asia Pacific Other Syringe Size Market by Country, 2017 - 2020, USD Million
TABLE 190 Asia Pacific Other Syringe Size Market by Country, 2021 - 2027, USD Million
TABLE 191 Asia Pacific Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 192 Asia Pacific Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 193 Asia Pacific Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 194 Asia Pacific Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 195 Asia Pacific Homecare Settings Market by Country, 2017 - 2020, USD Million
TABLE 196 Asia Pacific Homecare Settings Market by Country, 2021 - 2027, USD Million
TABLE 197 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 198 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 199 Asia Pacific Insulin Syringes Market by Country, 2017 - 2020, USD Million
TABLE 200 Asia Pacific Insulin Syringes Market by Country, 2021 - 2027, USD Million
TABLE 201 China Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 202 China Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 203 China Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 204 China Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 205 China Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 206 China Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 207 China Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 208 China Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 209 Japan Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 210 Japan Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 211 Japan Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 212 Japan Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 213 Japan Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 214 Japan Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 215 Japan Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 216 Japan Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 217 India Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 218 India Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 219 India Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 220 India Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 221 India Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 222 India Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 223 India Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 224 India Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 225 South Korea Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 226 South Korea Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 227 South Korea Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 228 South Korea Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 229 South Korea Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 230 South Korea Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 231 South Korea Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 232 South Korea Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 233 Singapore Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 234 Singapore Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 235 Singapore Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 236 Singapore Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 237 Singapore Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 238 Singapore Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 239 Singapore Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 240 Singapore Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 241 Malaysia Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 242 Malaysia Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 243 Malaysia Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 244 Malaysia Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 245 Malaysia Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 246 Malaysia Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 247 Malaysia Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 248 Malaysia Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 249 Rest of Asia Pacific Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 250 Rest of Asia Pacific Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 251 Rest of Asia Pacific Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 252 Rest of Asia Pacific Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 253 Rest of Asia Pacific Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 254 Rest of Asia Pacific Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 255 Rest of Asia Pacific Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 256 Rest of Asia Pacific Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 257 LAMEA Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 258 LAMEA Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 259 LAMEA Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 260 LAMEA Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 261 LAMEA Type 2 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 262 LAMEA Type 2 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 263 LAMEA Type 1 Diabetes Market by Country, 2017 - 2020, USD Million
TABLE 264 LAMEA Type 1 Diabetes Market by Country, 2021 - 2027, USD Million
TABLE 265 LAMEA Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 266 LAMEA Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 267 LAMEA 3/10 CC Syringe (0.3ml) Market by Country, 2017 - 2020, USD Million
TABLE 268 LAMEA 3/10 CC Syringe (0.3ml) Market by Country, 2021 - 2027, USD Million
TABLE 269 LAMEA 1/2 CC Syringe (0.5ml) Market by Country, 2017 - 2020, USD Million
TABLE 270 LAMEA 1/2 CC Syringe (0.5ml) Market by Country, 2021 - 2027, USD Million
TABLE 271 LAMEA 1CC Syringe (1ml) Market by Country, 2017 - 2020, USD Million
TABLE 272 LAMEA 1CC Syringe (1ml) Market by Country, 2021 - 2027, USD Million
TABLE 273 LAMEA Other Syringe Size Market by Country, 2017 - 2020, USD Million
TABLE 274 LAMEA Other Syringe Size Market by Country, 2021 - 2027, USD Million
TABLE 275 LAMEA Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 276 LAMEA Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 277 LAMEA Hospitals & Clinics Market by Country, 2017 - 2020, USD Million
TABLE 278 LAMEA Hospitals & Clinics Market by Country, 2021 - 2027, USD Million
TABLE 279 LAMEA Homecare Settings Market by Country, 2017 - 2020, USD Million
TABLE 280 LAMEA Homecare Settings Market by Country, 2021 - 2027, USD Million
TABLE 281 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 282 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 283 LAMEA Insulin Syringes Market by Country, 2017 - 2020, USD Million
TABLE 284 LAMEA Insulin Syringes Market by Country, 2021 - 2027, USD Million
TABLE 285 Brazil Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 286 Brazil Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 287 Brazil Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 288 Brazil Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 289 Brazil Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 290 Brazil Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 291 Brazil Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 292 Brazil Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 293 Argentina Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 294 Argentina Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 295 Argentina Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 296 Argentina Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 297 Argentina Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 298 Argentina Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 299 Argentina Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 300 Argentina Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 301 UAE Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 302 UAE Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 303 UAE Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 304 UAE Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 305 UAE Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 306 UAE Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 307 UAE Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 308 UAE Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 309 Saudi Arabia Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 310 Saudi Arabia Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 311 Saudi Arabia Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 312 Saudi Arabia Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 313 Saudi Arabia Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 314 Saudi Arabia Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 315 Saudi Arabia Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 316 Saudi Arabia Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 317 South Africa Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 318 South Africa Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 319 South Africa Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 320 South Africa Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 321 South Africa Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 322 South Africa Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 323 South Africa Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 324 South Africa Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 325 Nigeria Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 326 Nigeria Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 327 Nigeria Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 328 Nigeria Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 329 Nigeria Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 330 Nigeria Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 331 Nigeria Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 332 Nigeria Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 333 Rest of LAMEA Insulin Syringes Market, 2017 - 2020, USD Million
TABLE 334 Rest of LAMEA Insulin Syringes Market, 2021 - 2027, USD Million
TABLE 335 Rest of LAMEA Insulin Syringes Market by Disease, 2017 - 2020, USD Million
TABLE 336 Rest of LAMEA Insulin Syringes Market by Disease, 2021 - 2027, USD Million
TABLE 337 Rest of LAMEA Insulin Syringes Market by Syringe Size, 2017 - 2020, USD Million
TABLE 338 Rest of LAMEA Insulin Syringes Market by Syringe Size, 2021 - 2027, USD Million
TABLE 339 Rest of LAMEA Insulin Syringes Market by End User, 2017 - 2020, USD Million
TABLE 340 Rest of LAMEA Insulin Syringes Market by End User, 2021 - 2027, USD Million
TABLE 341 Key Information – Hindustan Syringes & Medical Devices Ltd.
TABLE 342 Key information – Novo Nordisk A/S
TABLE 343 Key Information – Biocon Limited
TABLE 344 Key Information – Eli Lilly and Company
TABLE 345 Key Information – Abbott Laboratories
TABLE 346 Key information – Becton, Dickinson and Company
TABLE 347 key information – Cardinal Health, Inc.
TABLE 348 Key Information – Medline Industries, Inc.
TABLE 349 Key Information – Terumo Corporation
TABLE 350 Key Information – Nipro Corporation

List of Figures
FIG 1 Methodology for the research